Gartner, Inc. Cost of Revenue
Gartner, Inc. (IT) reported Cost of Revenue of $486.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- Gartner, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $486.91M, a 8.43% decline year-over-year.
- Gartner, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $429.31M, a 9.63% decline year-over-year.
- Gartner, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $572.60M, a 0.41% decline year-over-year.
- Gartner, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $474.22M, a 0.24% decline year-over-year.
- Gartner, Inc. cost of goods and services sold for fiscal 2025 was $2.05B, a 1.51% increase from fiscal 2024.
- Gartner, Inc. cost of goods and services sold for fiscal 2024 was $2.02B, a 6.29% increase from fiscal 2023.
- Gartner, Inc. cost of goods and services sold for fiscal 2023 was $1.90B, a 12.37% increase from fiscal 2022.
- Gartner, Inc. cost of goods and services sold for fiscal 2022 was $1.69B, a 17.29% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $486.91M 10-Q · filed 2026-08-04 | $916.22M 10-Q · filed 2026-08-04 | $1.49B derived: sum of 3 quarters · filed 2026-08-04 | $1.96B derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $429.31M 10-Q · filed 2026-05-05 | $1.00B derived: sum of 2 quarters · filed 2026-05-05 | $1.48B derived: sum of 3 quarters · filed 2026-05-05 | $2.01B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $572.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.05B derived: sum of 2 quarters · filed 2026-02-12 | $1.58B derived: sum of 3 quarters · filed 2026-08-04 | $2.05B 10-K · filed 2026-02-12 |
| 2025-09-30 | $474.22M 10-Q · filed 2025-11-04 | $1.01B derived: sum of 2 quarters · filed 2026-08-04 | $1.48B 10-Q · filed 2025-11-04 | $2.06B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $531.73M 10-Q · filed 2026-08-04 | $1.01B 10-Q · filed 2026-08-04 | $1.58B derived: sum of 3 quarters · filed 2026-08-04 | $2.06B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $475.03M 10-Q · filed 2026-05-05 | $1.05B derived: sum of 2 quarters · filed 2026-05-05 | $1.53B derived: sum of 3 quarters · filed 2026-05-05 | $2.04B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $574.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.05B derived: sum of 2 quarters · filed 2026-02-12 | $1.56B derived: sum of 3 quarters · filed 2026-02-12 | $2.02B 10-K · filed 2026-02-12 |
| 2024-09-30 | $475.34M 10-Q · filed 2025-11-04 | $988.66M derived: sum of 2 quarters · filed 2025-11-04 | $1.45B 10-Q · filed 2025-11-04 | $1.98B derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $513.31M 10-Q · filed 2025-08-05 | $972.75M 10-Q · filed 2025-08-05 | $1.50B derived: sum of 3 quarters · filed 2026-02-12 | $1.95B derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $459.44M 10-Q · filed 2025-05-06 | $989.28M derived: sum of 2 quarters · filed 2026-02-12 | $1.44B derived: sum of 3 quarters · filed 2026-02-12 | $1.93B derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $529.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $980.68M derived: sum of 2 quarters · filed 2026-02-12 | $1.47B derived: sum of 3 quarters · filed 2026-02-12 | $1.90B 10-K · filed 2026-02-12 |
| 2023-09-30 | $450.84M 10-Q · filed 2024-11-05 | $938.26M derived: sum of 2 quarters · filed 2024-11-05 | $1.37B 10-Q · filed 2024-11-05 | $1.85B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $487.42M 10-Q · filed 2024-07-30 | $922.56M 10-Q · filed 2024-07-30 | $1.40B derived: sum of 3 quarters · filed 2025-02-13 | $1.81B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $435.14M 10-Q · filed 2024-04-30 | $910.50M derived: sum of 2 quarters · filed 2025-02-13 | $1.33B derived: sum of 3 quarters · filed 2025-02-13 | $1.75B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $475.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $892.20M derived: sum of 2 quarters · filed 2025-02-13 | $1.32B derived: sum of 3 quarters · filed 2025-02-13 | $1.69B 10-K · filed 2025-02-13 |
| 2022-09-30 | $416.84M 10-Q · filed 2023-11-03 | $841.37M derived: sum of 2 quarters · filed 2023-11-03 | $1.22B 10-Q · filed 2023-11-03 | $1.62B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $424.54M 10-Q · filed 2023-08-01 | $801.57M 10-Q · filed 2023-08-01 | $1.20B derived: sum of 3 quarters · filed 2024-02-15 | $1.56B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $377.03M 10-Q · filed 2023-05-02 | $776.62M derived: sum of 2 quarters · filed 2024-02-15 | $1.14B derived: sum of 3 quarters · filed 2024-02-15 | $1.49B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $399.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $758.82M derived: sum of 2 quarters · filed 2024-02-15 | $1.11B derived: sum of 3 quarters · filed 2024-02-15 | $1.44B 10-K · filed 2024-02-15 |
| 2021-09-30 | $359.24M 10-Q · filed 2022-11-01 | $710.04M derived: sum of 2 quarters · filed 2022-11-01 | $1.04B 10-Q · filed 2022-11-01 | $1.40B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $350.80M 10-Q · filed 2022-08-02 | $685.27M 10-Q · filed 2022-08-02 | $1.04B derived: sum of 3 quarters · filed 2023-02-16 | $1.37B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $334.47M 10-Q · filed 2022-05-03 | $685.89M derived: sum of 2 quarters · filed 2023-02-16 | $1.02B derived: sum of 3 quarters · filed 2023-02-16 | $1.34B derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $351.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $681.20M derived: sum of 2 quarters · filed 2023-02-16 | $1.00B derived: sum of 3 quarters · filed 2023-02-16 | $1.35B 10-K · filed 2023-02-16 |
| 2020-09-30 | $329.77M 10-Q · filed 2021-11-02 | $652.32M derived: sum of 2 quarters · filed 2021-11-02 | $993.60M 10-Q · filed 2021-11-02 | $1.44B derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $322.55M 10-Q · filed 2021-08-03 | $663.83M 10-Q · filed 2021-08-03 | $1.11B derived: sum of 3 quarters · filed 2022-02-23 | $1.48B derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $341.28M 10-Q · filed 2021-05-04 | $792.15M derived: sum of 2 quarters · filed 2022-02-23 | $1.16B derived: sum of 3 quarters · filed 2022-02-23 | $1.55B derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $450.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $815.92M derived: sum of 2 quarters · filed 2022-02-23 | $1.20B derived: sum of 3 quarters · filed 2022-02-23 | $1.55B 10-K · filed 2022-02-23 |
| 2019-09-30 | $365.06M 10-Q · filed 2020-11-03 | $753.05M derived: sum of 2 quarters · filed 2020-11-03 | $1.10B 10-Q · filed 2020-11-03 | $1.51B derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $388.00M 10-Q · filed 2020-08-04 | $734.64M 10-Q · filed 2020-08-04 | $1.14B derived: sum of 3 quarters · filed 2021-02-24 | $1.48B derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $346.64M 10-Q · filed 2020-05-07 | $754.49M derived: sum of 2 quarters · filed 2021-02-24 | $1.09B derived: sum of 3 quarters · filed 2021-02-24 | $1.46B derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $407.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $743.95M derived: sum of 2 quarters · filed 2021-02-24 | $1.11B derived: sum of 3 quarters · filed 2021-02-24 | $1.47B 10-K · filed 2021-02-24 |
| 2018-09-30 | $336.11M 10-Q · filed 2019-10-31 | $703.75M derived: sum of 2 quarters · filed 2019-10-31 | $1.06B 10-Q · filed 2019-10-31 | $1.46B derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $367.64M 10-Q · filed 2019-07-30 | $724.85M 10-Q · filed 2019-07-30 | $1.12B derived: sum of 3 quarters · filed 2020-02-19 | $1.46B derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $357.21M 10-Q · filed 2019-05-07 | $755.59M derived: sum of 2 quarters · filed 2020-02-19 | $1.09B derived: sum of 3 quarters · filed 2020-02-19 | $1.44B derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $398.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $730.59M derived: sum of 2 quarters · filed 2020-02-19 | $1.08B derived: sum of 3 quarters · filed 2020-02-19 | $1.32B 10-K · filed 2020-02-19 |
| 2017-09-30 | $332.21M 10-Q · filed 2018-11-01 | $684.21M derived: sum of 2 quarters · filed 2018-11-01 | $921.82M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $352.00M 10-Q · filed 2018-08-01 | $589.61M 10-Q · filed 2018-08-01 | ||
| 2016-12-31 | $945.65M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |